You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTX Exercise Disclosure
Bazemore Robert B · SEC Form 4 · Filed Oct 16, 2026
Exercise
Calculated transaction value
$12.49K
Bazemore Robert B Director
AKTX
Transaction date
Oct 14, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 2 days later
AKTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrant to Purchase ADSs on American Depositary Shares representing Ordinary Shares
- Quantity / price
- 773 shares @ $16.16
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-047455
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$202.9K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $0.31 |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $1.24 |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $49.98K |
| Akari Therapeutics Plc AKTX Current | Exercise | Oct 14, 2026 | $12.49K |
| Akari Therapeutics Plc AKTX | Award | Oct 5, 2026 | $36.94K |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $0 |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $0 |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $103.48K |